Search clinical trials for: anti-D prophylaxis

Total 2434 results

Duke University
National Institute of Mental Health (NIMH); Louisiana State University Health...

Enrolling by invitation

Start the Conversation: Evaluating Implementation of a Multi-level PrEP Initiative for Black Cisgender Women in Nola

HIV Infections | Preexposure Prophylaxis

United States
Emory University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System (ePrEP)

Pre-exposure Prophylaxis

United States
Mayo Clinic

Enrolling by invitation

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Autoimmune Diseases | Diabetes | Chronic Kidney Diseases | Tobacco Use | Overweight or Obesity | Inflammatory Disease | MRSA | Infections Joint Prosthetic | MSSA Colonization

United States
Hoffmann-La Roche

Active, not recruiting

Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants (HAVEN 5)

Hemophilia A

China, Thailand, Hong Kong, Malaysia
Amgen

Completed

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout (MIRROR OL)

Gout

United States
Amgen

Completed

Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout (MIRROR RCT)

Gout

United States
Romark Laboratories L.C.

Completed

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

COVID-19 | Viral Respiratory Illnesses

United States
AstraZeneca

Active, not recruiting

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study (SUPERNOVA)

COVID-19, SARS-CoV-2

United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
AstraZeneca

Completed

An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan (Evusheld DBR)

COVID-19

Japan
University of Wisconsin, Madison
National Cancer Institute (NCI)

Terminated

Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

Breast Cancer | Breast Neoplasms

United States
BioCryst Pharmaceuticals

Active, not recruiting

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies (APeX-A)

Hereditary Angioedema | HAE

France, North Macedonia, Poland, Korea, Republic of, Slovakia, South Africa, Czechia
Nordic Lymphoma Group
Helsinki University Central Hospital; Aarhus University Hospital

Active, not recruiting

Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis (Bio-CHIC)

Lymphoma, Large B-Cell, Diffuse

Norway, Denmark, Sweden, Finland
University of Witwatersrand, South Africa
ViiV Healthcare

Active, not recruiting

Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa (AXIS)

HIV Infections

South Africa
University of California, San Francisco
National Institute of Mental Health (NIMH); Santa Casa Medical School

Active, not recruiting

Reducing Intersectional Stigma Among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP (PRISM Brazil)

HIV Prevention

Brazil
Janssen Research & Development, LLC

Active, not recruiting

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus (REEF-D)

Hepatitis D, Chronic

France, Taiwan, Italy, Germany, Japan, Spain, Russian Federation, Turkey, United Kingdom, Australia, Sweden, United States, New Zealand, China, Brazil
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Alignment of PrEP Use With HIV Risk in Young Women and Men

HIV Infections | Sexually Transmitted Diseases, Bacterial | Pre-Exposure Prophylaxis

Uganda
Brigham and Women's Hospital
The Fenway Institute

Active, not recruiting

Next Generation Ingestible Sensors for Medication Adherence Measurement (NextGen)

HIV Infection | Adherence, Medication | Antiretroviral Therapy | Adherence, Treatment | Pre-Exposure Prophylaxis

United States
Brigham and Women's Hospital
Gilead Sciences; The Fenway Institute

Completed

Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps) (PrEPSteps)

HIV Infections | Substance Use Disorders

United States
Monica Bhatia

Completed

Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

Sickle Cell Disease | Graft Versus Host Disease

United States
Columbia University
Yale University; Fogarty International Center of the National Institute of...

Active, not recruiting

Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries

Human Immunodeficiency Virus

United States, Romania
Bayer

Active, not recruiting

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood (Alfa-PROTECT)

Hemophilia A | Children | Prophylaxis of Bleeding | Treatment of Bleeding

Canada, United States, Brazil, Italy, Turkey, Argentina, Norway
Al-Rasheed University College

Completed

Gentamicin in Cardiac Surgery

Cardiac Infection

Iraq
AstraZeneca

Active, not recruiting

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

COVID-19

United States
Ain Shams University

Completed

Role of Fenofibrate in Neonatal Jaundice

Neonatal Jaundice

Egypt
Yizhuo Zhang

Active, not recruiting

Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study

Ewing Sarcoma | Risk Stratification

China
Johns Hopkins Bloomberg School of Public Health
National Institute of Mental Health (NIMH); TB/HIV Care; Community Media Trust

Completed

Le Kip Kip: A Campaign to Change Social Norms and Build Sustainable Demand for PrEP Among Women in South Africa

HIV Infections | Pre-exposure Prophylaxis

South Africa
Universitair Ziekenhuis Brussel

Active, not recruiting

Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis

Human Papilloma Virus

Belgium
Pfizer

Completed

Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults

Migraine

United States
Institut de Recherche pour le Developpement
Chiang Mai University; Ministry of Health, Thailand; Ministry of Health, Lao PDR

Active, not recruiting

Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection

Hepatitis B | Pregnancy

Thailand, Lao People's Democratic Republic
University of Washington
National Institute on Drug Abuse (NIDA)

Completed

Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users

HIV/AIDS | Adherence, Medication | Drug Use

United States
Columbia University

Active, not recruiting

Making PrEP Smart: An HIV Testing and PrEP Electronic Support Tool ("SmartPrEP" App) for Women on PrEP

HIV/AIDS

United States
Emory University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)

HIV Infections

United States
Prof. Wolfgang Janni
Roche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbH

Active, not recruiting

Detect V / CHEVENDO (Chemo vs. Endo)

Metastatic Breast Cancer

Germany
University of Washington
National Institute of Mental Health (NIMH)

Completed

Streamlining the Efficiency of PrEP Implementation (Efficiency)

HIV Prevention | HIV Preexposure Prophylaxis | Implementation

Kenya
Weill Medical College of Cornell University
National Cancer Institute (NCI)

Completed

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy (PREVENT)

Infection

United States
AstraZeneca

Active, not recruiting

Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries (EVOLVE)

COVID-19

United Arab Emirates
Merck Sharp & Dohme LLC

Active, not recruiting

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

HIV | HIV Pre-exposure Prophylaxis

United States, Israel, South Africa
Centers for Disease Control and Prevention
Gilead Sciences; CDC Foundation

Completed

Sustainable Healthcenter Implementation PrEP Pilot Study (SHIPP)

HIV Preexposure Prophylaxis | HIV Chemoprophylaxis

United States
Eledon Pharmaceuticals

Enrolling by invitation

Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

Kidney Transplant Rejection

Australia, Canada
AstraZeneca

Completed

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19 (NOVELLA)

COVID-19, SARS-CoV-2

Russian Federation
Indiana University
National Institutes of Health (NIH); National Center for Advancing Translational... and other collaborators

Enrolling by invitation

Adapting an Adolescent Friendly PrEP Program for Uasin Gishu County-Kenya

Stigma, Social | HIV Pre-exposure Prophylaxis

Kenya
Organon and Co

Completed

A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis

Migraine
University of California, San Francisco
National Institute on Minority Health and Health Disparities (NIMHD); Florida...

Completed

The OPENS Trial: Offering Women PrEP (Aim 1)

Sexually Transmitted Diseases | Human Immunodeficiency Virus Transmission

United States
Jennifer Woyach
Pharmacyclics LLC.

Active, not recruiting

Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
MedSIR
Gilead Sciences

Active, not recruiting

Preventive stRategy for IMMU132-relatED AEs in TNBC - PRIMED (PRIMED)

Breast Cancer | Triple Negative Breast Cancer

Spain
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis (Beyond ABR)

Severe Hemophilia A | Moderate Hemophilia A

Brazil, Germany, Italy, Spain, United States, Turkey, United Kingdom, Tunisia, Canada, Hungary, Morocco, Serbia
University of Chicago
National Institute of Mental Health (NIMH); Ann & Robert H Lurie Children's... and other collaborators

Completed

Project WERK (Wellness Encouragement Respect Kinship) (WERK)

HIV Prevention

United States
University of Texas Southwestern Medical Center

Completed

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

COVID-19 | Respiratory Viral Infection | Antiviral Treatment

United States
Emory University
National Institute of Mental Health (NIMH)

Completed

Pre-exposure Prophylaxis (PrEP) at Home (PrEP@Home)

HIV/AIDS

United States
Universidad Autonoma de San Luis Potosí

Completed

Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.

Migraine Headache

Mexico

Search clinical trials for: anti-D prophylaxis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations